{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/scarlet-fever/diagnosis/differential-diagnosis/","result":{"pageContext":{"chapter":{"id":"a1df37ba-9251-52d5-8376-b19803e39cc3","slug":"differential-diagnosis","fullItemName":"Differential diagnosis","depth":2,"htmlHeader":"<!-- begin field 036ddc82-e21e-4046-bb10-f1868d0af0b8 --><h2>What else might it be?</h2><!-- end field 036ddc82-e21e-4046-bb10-f1868d0af0b8 -->","summary":"","htmlStringContent":"<!-- begin item 003a4015-31c3-4dfb-8b8e-51675d3d1655 --><!-- begin field ae68068f-0323-4c3f-bacd-a029ef9cf583 --><p><strong>Alternative diagnoses that may present similarly to scarlet fever include:</strong></p><ul><li>Rubella — this typically causes a non-confluent, maculopapular rash that starts behind the ears, spreads to the face and neck, and then to the trunk and extremities. The rash is transient, lasting between 3–5 days, and there may be associated cervical lymphadenopathy. See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/rubella/\">Rubella</a> for more information.</li><li>Parvovirus B19 infection — this often presents with a diffuse erythematous facial rash appearing on one or both cheeks (resembling a 'slapped cheek') in children. An erythematous maculopapular rash on the trunk, back, and limbs may develop a few days after the facial rash. See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/parvovirus-b19-infection/\">Parvovirus B19 infection</a> for more information. </li><li>Measles — this causes a characteristic erythematous and maculopapular rash that may become confluent as it progresses. It appears on the face and behind the ears first before spreading to the trunk and limbs over the course of about 3–4 days. It is usually accompanied by severe symptoms of viraemia (malaise, fever, loss of appetite, cough, rhinorrhoea, and conjunctivitis) and sore throat is not prominent. See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/measles/\">Measles</a> for more information. </li><li>Roseola infantum (herpesvirus type 6) — this causes a generalized pink papular or maculopapular rash. It usually starts on the trunk before spreading to the face and limbs. </li><li>Enterovirus and adenovirus infections — these are common causes of erythematous maculopapular viral rashes. </li><li>Kawasaki disease — this may be a cause of fever that has lasted 5 days or longer, and may also present with an erythematous polymorphous rash, strawberry tongue, cervical lymphadenopathy, bilateral conjunctivitis, and oedema, erythema, and skin peeling of the hands and feet. See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/feverish-children-risk-assessment/\">Feverish children - risk assessment</a> for more information.</li><li>Staphylococcal toxic shock syndrome (TSS) — this is a potentially life-threatening condition, and symptoms may include fever, headache, skin rash, confusion, vomiting, or diarrhoea. Risk factors include tampon use, the postpartum period, staphylococcal skin or soft tissue infections, and comorbid influenza infection.</li><li>Brucellosis, cytomegalovirus, toxoplasmosis, HIV, syphilis, and mononucleosis reaction to amoxicillin — these may all cause rash accompanied with lymphadenopathy. See the CKS topics on <a class=\"topic-reference external-reference\" href=\"/topics/lyme-disease/\">Lyme disease</a>, <a class=\"topic-reference external-reference\" href=\"/topics/hiv-infection-aids/\">HIV infection and AIDS</a>, <a class=\"topic-reference external-reference\" href=\"/topics/syphilis/\">Syphilis</a>, and <a class=\"topic-reference external-reference\" href=\"/topics/glandular-fever-infectious-mononucleosis/\">Glandular fever (infectious mononucleosis)</a> for more information.</li><li>Other adverse drug reactions, echovirus, Coxsackievirus, and viral hepatitis — although these cause a rash they are not usually associated with lymphadenopathy.</li><li>Tropical viruses, including alphaviruses and flaviviruses (for example Dengue fever), rare — these should be considered if the person has recently travelled to affected areas. </li></ul><!-- end field ae68068f-0323-4c3f-bacd-a029ef9cf583 --><!-- end item 003a4015-31c3-4dfb-8b8e-51675d3d1655 -->","topic":{"id":"7c05f7c5-902d-5982-8cc9-5f1d301d214d","topicId":"f534013d-38dd-4f96-bc65-37091262952c","topicName":"Scarlet fever","slug":"scarlet-fever","lastRevised":"Last revised in March 2020","chapters":[{"id":"d3f6c278-a759-50f3-9a96-734913f439ab","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"ffff4a88-7ddf-55dc-a37b-1625f3f58e2b","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"89be33c0-acbe-51fd-901b-d7cf571435a4","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"61377ddb-df7a-50fb-9dd7-224014332a4e","slug":"changes","fullItemName":"Changes"},{"id":"b5e95aca-9003-52f8-b6e7-0c192c5ba757","slug":"update","fullItemName":"Update"}]},{"id":"90d2085f-63f5-57a1-b21e-21d4c580229a","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"cc3aa630-ef6b-5504-9439-6a4757e7fe43","slug":"goals","fullItemName":"Goals"},{"id":"ebf64432-58f2-513f-a393-ec4e8438f355","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"b3da9abe-7cc8-5c97-970d-39b1416de8cb","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"8b3309e1-1d9f-520e-b310-592706c0951d","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"0603af50-edd7-5e78-a394-1fd6a1a1af21","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"00da52ed-356a-563d-aa3c-dc4e3ee27155","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"7072120a-72ec-5945-b4f0-e4386374e1ad","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"f61354f7-80ff-5483-89fc-51be1d57b5d3","slug":"definition","fullItemName":"Definition"},{"id":"4dc22989-c1d3-5880-a381-78cabd38ca4d","slug":"transmission","fullItemName":"Transmission"},{"id":"c4e4e4ff-9b93-5d55-8ae0-5e0b1a518ef3","slug":"risk-factors","fullItemName":"Risk factors"},{"id":"5b31f083-75b7-5ae3-9029-87df9bc061cf","slug":"prevalence","fullItemName":"Prevalence"},{"id":"94ffb885-96f6-595f-b1ad-fb146a27db30","slug":"complications","fullItemName":"Complications"},{"id":"f3bf38a0-7946-504a-b22c-654728a0366a","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"ffb84f0d-77eb-5011-a50d-14d9143e4bd4","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"8484304f-9507-5401-8c08-2c93126a8b3f","slug":"diagnosis","fullItemName":"Diagnosis"},{"id":"601ddd63-7670-5740-a0f6-fe317e0d7770","slug":"investigations","fullItemName":"Investigations"},{"id":"a1df37ba-9251-52d5-8376-b19803e39cc3","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"5329e2f2-3618-5113-8fc1-5228ff864869","fullItemName":"Management","slug":"management","subChapters":[{"id":"963d805b-33a2-5e78-9195-323379519c7e","slug":"management","fullItemName":"Scenario: Management"}]},{"id":"db4a097c-9d97-5e1e-8718-e082e8e25f5e","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"4a26593a-c9e4-5523-a6d2-5feb274dcf79","slug":"phenoxymethylpenicillin","fullItemName":"Phenoxymethylpenicillin"},{"id":"2a494a84-0688-5337-8f03-a2ab33a654fb","slug":"amoxicillin","fullItemName":"Amoxicillin"},{"id":"ce256942-e7de-5014-bdf7-f34be5755538","slug":"azithromycin","fullItemName":"Azithromycin"}]},{"id":"7e3b4438-f437-5199-8ee5-f3c9d210b732","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"f2446794-c34e-574f-8de3-c5ecbe3c4f35","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"1a90ff7f-b2b6-5959-86a0-3cea6609706f","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"0d14df6f-1299-58da-b620-c970e5b90b91","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"db42b54d-b095-52b7-9cb1-37d73c57fdb7","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"551dac2a-e65d-57c4-b16c-279891510a2b","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"5d76e530-4218-5600-a9ed-896a3245aefb","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"03221ed8-00f7-5819-b90c-cc69c4a1fdb8","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"ffb84f0d-77eb-5011-a50d-14d9143e4bd4","slug":"diagnosis","fullItemName":"Diagnosis"},"subChapters":[{"id":"576a34c3-0cda-5f3f-afcd-6cf5b9f8312e","slug":"basis-for-recommendation-992","fullItemName":"Basis for recommendation","depth":3,"htmlHeader":"<!-- begin field 7e38a057-278e-4bdf-8ca3-14e6d1d7f02a --><h3>Basis for recommendation</h3><!-- end field 7e38a057-278e-4bdf-8ca3-14e6d1d7f02a -->","summary":null,"htmlStringContent":"<!-- begin item 99220cb1-f54e-4d45-8b48-2802a3eba4a3 --><!-- begin field 14716482-2cbb-43d8-9d57-1b3815521419 --><p>The information on differential diagnosis of scarlet fever is based on expert opinion in the Public Health England (PHE) publication <em>Guidelines for the public health management of scarlet fever outbreaks in schools, nurseries and other childcare settings</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/scarlet-fever/references/\">PHE, 2017</a>], and expert opinion in review articles on rashes [<a class=\"bibliography-reference internal-reference\" href=\"/topics/scarlet-fever/references/\">Ramsay, 2002</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/scarlet-fever/references/\">Watkins, 2008</a>] and on scarlet fever [<a class=\"bibliography-reference internal-reference\" href=\"/topics/scarlet-fever/references/\">Holden, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/scarlet-fever/references/\">Basetti, 2017</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/scarlet-fever/references/\">DTB, 2018</a>], information in a medical textbook on streptococcal pharyngitis [<a class=\"bibliography-reference internal-reference\" href=\"/topics/scarlet-fever/references/\">Wessels, 2016</a>], and information in an infectious diseases textbook on scarlet fever [<a class=\"bibliography-reference internal-reference\" href=\"/topics/scarlet-fever/references/\">Bisno, 2010</a>].</p><!-- end field 14716482-2cbb-43d8-9d57-1b3815521419 --><!-- end item 99220cb1-f54e-4d45-8b48-2802a3eba4a3 -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}